Tumor regression induced by YM155, a novel, survivin suppressant, in human diffuse large B-cell lymphoma models

被引:0
|
作者
Kaneko, Naoki [1 ]
Kita, Aya [1 ]
Nakahara, Takahito [1 ]
Nakata, Mari [1 ]
Koutoku, Hiroshi [1 ]
Sasamata, Masao [1 ]
机构
[1] Astellas Pharma Inc, Appl Pharmacol Res Labs, Tsukuba, Ibaraki 3058585, Japan
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:260P / 260P
页数:1
相关论文
共 50 条
  • [31] Antitumor effect of YM155, a novel small-molecule survivin suppressant, via mitochondrial apoptosis in human MFH/UPS
    Minoda, Masaya
    Kawamoto, Teruya
    Ueha, Takeshi
    Kamata, Etsuko
    Morishita, Masayuki
    Harada, Risa
    Toda, Mitsunori
    Onishi, Yasuo
    Hara, Hitomi
    Kurosaka, Masahiro
    Akisue, Toshihiro
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (03) : 891 - 899
  • [32] Sepantronium Bromide (YM155) Enhances Response of Human B-Cell Non-Hodgkin Lymphoma to Rituximab
    Kita, Aya
    Mitsuoka, Keisuke
    Kaneko, Naoki
    Nakata, Mari
    Yamanaka, Kentaro
    Jitsuoka, Makoto
    Miyoshi, Sosuke
    Noda, Akihiro
    Mori, Masamichi
    Nakahara, Takahito
    Sasamata, Masao
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2012, 343 (01): : 178 - 183
  • [33] Antitumor efficacy and biodistribution of liposomal sepantronium bromide (YM155), a novel small-molecule survivin suppressant
    Kawano, Hiroki
    Shakushiro, Kohsuke
    Nakata, Mari
    Kita, Aya
    Maeda, Atsushi
    Watanabe, Shunsuke
    Sako, Kazuhiro
    Oku, Naoto
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 88 (01) : 283 - 289
  • [34] Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models
    Nakahara, Takahito
    Kita, Aya
    Yamanaka, Kentaro
    Mori, Masamichi
    Amino, Nobuaki
    Takeuchi, Masahiro
    Tominaga, Fumiko
    Kinoyama, Isao
    Matsuhisa, Akira
    Kudou, Masafumi
    Sasamata, Masao
    CANCER SCIENCE, 2011, 102 (03) : 614 - 621
  • [35] YM155, a Novel Small-Molecule Survivin Suppressant, Induces Regression of Established Human Hormone-Refractory Prostate Tumor Xenografts (vol 67, pg 8014, 2007)
    Nakahara, Takahito
    Kita, Aya
    Yamanaka, Kentaro
    Mori, Masamichi
    Amino, Nobuaki
    Takeuchi, Masahiro
    Tominaga, Fumiko
    Hatakeyama, Shinji
    Kinoyama, Isao
    Matsuhisa, Akira
    Kudou, Masafumi
    Sasamata, Masao
    CANCER RESEARCH, 2012, 72 (15) : 3886 - 3886
  • [36] Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma
    Yu-Fan Wang
    Wei Zhang
    Ke-Fei He
    Bing Liu
    Lu Zhang
    Wen-Feng Zhang
    Ashok B. Kulkarni
    Yi-Fang Zhao
    Zhi-Jun Sun
    Apoptosis, 2014, 19 : 748 - 758
  • [37] Radiosensitizing Effect of YM155, a Novel Small-Molecule Survivin Suppressant, in Non-Small Cell Lung Cancer Cell Lines
    Iwasa, Tsutomu
    Okamoto, Isamu
    Suzuki, Minoru
    Nakahara, Takahito
    Yamanaka, Kentaro
    Hatashita, Erina
    Yamada, Yuki
    Fukuoka, Masahiro
    Ono, Koji
    Nakagawa, Kazuhiko
    CLINICAL CANCER RESEARCH, 2008, 14 (20) : 6496 - 6504
  • [38] Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma
    Wang, Yu-Fan
    Zhang, Wei
    He, Ke-Fei
    Liu, Bing
    Zhang, Lu
    Zhang, Wen-Feng
    Kulkarni, Ashok B.
    Zhao, Yi-Fang
    Sun, Zhi-Jun
    APOPTOSIS, 2014, 19 (04) : 748 - 758
  • [39] Antitumor Activity of YM155, a Selective Small-Molecule Survivin Suppressant, Alone and in Combination with Docetaxel in Human Malignant Melanoma Models
    Yamanaka, Kentaro
    Nakahara, Takahito
    Yamauchi, Tomohiro
    Kita, Aya
    Takeuchi, Masahiro
    Kiyonaga, Fumiko
    Kaneko, Naoki
    Sasamata, Masao
    CLINICAL CANCER RESEARCH, 2011, 17 (16) : 5423 - 5431
  • [40] Concomitant and sequential administration of YM155 and docetaxel enhances apoptosis and tumor regression in human tumor xenograft models
    Yamanaka, Kentaro
    Nakahara, Takahito
    Kita, Aya
    Takeuchi, Masahiro
    Kinoyama, Isao
    Matsuhisa, Akira
    Koutoku, Hiroshi
    Sasamata, Masao
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3520S - 3521S